Hotline:
+ 49 (0) 2204 2918806

Market studies for category Therapeutic Area

Items 1 to 10 of 4533 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 454
  1. Net price*
    Year
  2. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Epistaxis – Pipeline Review, H2 2012

    Global Markets Direct
    25 pages
    Introduction Global Markets Direct’s, 'Epistaxis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Epistaxis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key play
    Englisch | Report | SKU: 318242
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Birch Pollen Allergy – Pipeline Review, H1 2013

    Global Markets Direct
    40 pages
    Introduction Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It
    Englisch | Report | SKU: 329748
  4. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Global Markets Direct
    154 pages
    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 987678277
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Diabetes – Pipeline Review, H1 2013

    Global Markets Direct
    359 pages
    Introduction Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key player
    Englisch | Report | SKU: 318882
  6. $3,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea’s Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)

    GBI Research
    111 pages
    GBI Research, the leading business intelligence provider, has released its latest research, "Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea’s Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)", which provides insights into the global ophthalmology therapeu
    Englisch | | SKU: 303469
  7. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Helicobacter Pylori Infections - Pipeline Review, H1 2014

    Global Markets Direct
    79 pages
    Global Markets Direct’s, ‘Helicobacter Pylori Infections - Pipeline Review, H1 2014’, provides an overview of the Helicobacter Pylori Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stag
    Englisch | Zukunftsanalyse | SKU: 403979
  8. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2014

    Global Markets Direct
    80 pages
    Global Markets Direct’s, ‘Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2014’, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrom
    Englisch | Zukunftsanalyse | SKU: 393933
  9. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Cancer Cachexia – Pipeline Review, H2 2012

    Global Markets Direct
    85 pages
    Introduction Global Markets Direct’s, 'Cancer Cachexia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cancer Cachexia, complete with latest updates, and special features on late-stage and discontinued projects. It also revi
    Englisch | Report | SKU: 317954
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014

    Global Markets Direct
    569 pages
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler's Disease), complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 393976
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myocardial Infarction – Pipeline Review, H1 2013

    Global Markets Direct
    235 pages
    Introduction Global Markets Direct’s, 'Myocardial Infarction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Report | SKU: 318594

Items 1 to 10 of 4533 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 454